MEDI-551 Treatment Effectively Depletes B Cells and Reduces Serum Titers of Autoantibodies in Mice Transgenic forSle1and Human CD19

Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.39503
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

389 Chromatin Accessibility Signatures in Human Blood CD4+ T and CD19+ B Cells

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Teriflunomide Treatment Reduces B Cells in Patients With MS

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2017English

B Cell Receptors in TCL1 Transgenic Mice Resemble Those of Aggressive, Treatment-Resistant Human Chronic Lymphocytic Leukemia

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's Mice

Journal of Neuroscience
Neuroscience
2010English

Continuous Zebularine Treatment Effectively Sustains Demethylation in Human Bladder Cancer Cells

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2004English

Estrogen Treatment Abrogates Neointima Formation in Human C-Reactive Protein Transgenic Mice

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2005English

Transgenic Expression of Human Signal Regulatory Protein Alpha in Rag2-/- C-/- Mice Improves Engraftment of Human Hematopoietic Cells in Humanized Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Human Prion Strain Selection in Transgenic Mice

Annals of Neurology
Neurology
2010English

piggyBacTransposon/Transposase System to Generate CD19-Specific T Cells for the Treatment of B-Lineage Malignancies

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy